1. Market Research
  2. > Therapy Industry

melanoma Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Cancer, Therapy, Vaccine, Diagnostics, Lung Cancer, Biopsy, Dermatology, Dermatological Condition, Pharmaceutical, Antiviral, Breast Cancer, Cancer Diagnostic, Cancer Immunotherapy, Health Care Provider, Infectious Disease, Laboratory, Lymphoma, Molecular Diagnostic, Prostate Cancer, Sets And Kits.


 
1-10 of 69 reports for melanoma

Purchase Reports From Reputable Market Research Publishers

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2022

  • $ 3000
  • Industry report
  • July 2017
  • by RNCOS

Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy ...

Uveal Melanoma - Pipeline Insight, 2017

  • $ 1250
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Uveal Melanoma-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Uveal Melanoma. The report provides a complete ...

Melanoma - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H1 2017, provides an overview of the Melanoma ...

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

NPS+ (EU5) [Melanoma]

  • $ 2745
  • Industry report
  • June 2017
  • by Firstword Pharma

Leading melanoma treatments may have a differentiation problem Two melanoma treatments are comfortably ahead of the pack in the EU5, earning by far the highest satisfaction scores from medical oncologists. ...

NPS+ (US) [Melanoma]

  • $ 2745
  • Industry report
  • June 2017
  • by Firstword Pharma

Is lack of experience hurting doctors’ perceptions of your brand? Lack of experience may be keeping two melanoma treatments from earning higher satisfactions scores. Results of our survey show that ...

Uveal Melanoma - Pipeline Review, H1 2017

  • $ 2000
  • Company report
  • April 2017
  • by Global Markets Direct

Uveal Melanoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma - Pipeline Review, H1 2017, provides an overview of ...

The 2018-2023 World Outlook for Melanoma Diagnostics and Therapeutics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for melanoma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

The 2018-2023 World Outlook for Melanoma Therapeutics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

Global Melanoma Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • April 2017
  • by Currentpartnering

Provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Melanoma Partnering Terms and Agreements ...

About 5200 reports for melanoma

Download Unlimited Documents from Trusted Public Sources

UK - Economic Analysis

  • July 2015
    246 pages
  • Therapy  

    Hospital  

    Mortality  

  • United Kingdom  

View report >

Uk - Economic Analysis

January 2015

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.